Zobrazeno 1 - 10
of 127
pro vyhledávání: '"J. Lori"'
Publikováno v:
Annals of Global Health, Vol 81, Iss 1 (2015)
Externí odkaz:
https://doaj.org/article/2461c730f0824dc7ab618a9d99309f02
Publikováno v:
Frontiers in Immunology, Vol 4 (2013)
The capacity to probe antigen specific T cells within the polyclonal repertoire has been revolutionized by the advent of recombinant peptide:MHC (pMHC) technology. Monomers and multimers of peptide: MHC molecules can enrich for and identify antigen s
Externí odkaz:
https://doaj.org/article/d06218f02dd4491d98a6de7806697891
Publikováno v:
Frontiers in Immunology, Vol 3 (2012)
Myelin-specific induction of tolerance represents a promising means to modify the course of autoimmune inflammatory demyelinating diseases such as multiple sclerosis (MS). Our laboratory has focused on a novel preclinical strategy for the induction o
Externí odkaz:
https://doaj.org/article/80f17742a4f7415bb4cc76b0daed707a
Autor:
Barr, Mayalin, Blanchfield, J Lori, Bluestone, Jeffrey A, Buchanan, Jeanne, Bundy, Brian N, Cabbage, Joanne, Coleman, Peter, De La Vega, Monica, DiMeglio, Linda A, Evans-Molina, Carmella, Felner, Eric I, Ferrannini, Ele, Ferrara, Christine, Gaglia, Jason L, Gitelman, Stephen E, Gottlieb, Peter A, Healy, Felicity, Higgins, Laurie, Hildinger, Megan, Jenkins, Margaret, Kayton Bryant, Nora, Kinderman, Amanda, Koshy, Nisha, Kost, Brianne, Krischer, Jeffrey P, Krishfield, Suzanne, Kucheruk, Olena, Lim, Noha, Lindsley, Karen, Long, S Alice, Mantravadi, Manasa, Mari, Andrea, Mesfin, Shelley, Michels, Aaron, Migre, Mary Ellen, Minnock, Pantea, Mirmira, Raghavendra G, Mohammed-Nur, Elham, Nelson, Jennifer, Nursing, Ashvin, O'Donnell, Ryan, Olivos, Diana, Parker, Melissa, Raskin, Philip, Redl, Leanne, Reed, Nicole, Resnick, Brittany, Sanda, Srinath, Sayre, Peter, Serti, Elisavet, Sims, Emily, Smith, Karen, Soppe, Carol, Stuart, Fiona, Szubowicz, Sarah, Tansey, Michel, Terrell, Jennifer, Tersey, Sarah, Torok, Christine, Tsalikian, Eva, Watson, Kelly, Wentworth, John M, Wesch, Rebecca, Willi, Steven, Woerner, Stephanie, Willi, Steven M
Publikováno v:
In The Lancet Diabetes & Endocrinology August 2021 9(8):502-514
Autor:
Emily K. Sims, Abhishek Kulkarni, Audrey Hull, Stephanie E. Woerner, Susanne Cabrera, Lucy D. Mastrandrea, Batoul Hammoud, Soumyadeep Sarkar, Ernesto Nakayasu, Teresa L. Mastracci, Susan M. Perkins, Fangqian Ouyang, Bobbie-Jo Webb-Robertson, Jacob Enriquez, Sarah Tersey, Carmella Evans-Molina, Alice Long, J. Lori Blanchfield, Eugene W. Gerner, Raghavendra G. Mirmira, Linda A. DiMeglio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf194459eb879a9aed256fcf023d33bd
https://doi.org/10.2139/ssrn.4417788
https://doi.org/10.2139/ssrn.4417788
Autor:
E. Coularou, A. Huneau, R. Thomas, V. Bellingard, J. Lori, P. Carpentier, N. Rousset, S. Le Bouquin-Leneveu
Publikováno v:
Animal - science proceedings. 13:619-620
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yang, Jennie H. M., Ward‐Hartstonge, Kirsten A., Perry, Daniel J., Blanchfield, J. Lori, Posgai, Amanda L., Wiedeman, Alice E., Diggins, Kirsten, Rahman, Adeeb, Tree, Timothy I. M., Brusko, Todd M., Levings, Megan K., James, Eddie A., Kent, Sally C., Speake, Cate, Homann, Dirk, Long, S. Alice
Publikováno v:
Eur J Immunol
Cytometric immunophenotyping is a powerful tool to discover and implement T-cell biomarkers of type 1 diabetes (T1D) progression and response to clinical therapy. Although many discovery-based T-cell biomarkers have been described, to date, no such m
Autor:
Gitelman, Stephen E, Bundy, Brian N, Ferrannini, Ele, Lim, Noha, Blanchfield, J Lori, DiMeglio, Linda A, Felner, Eric I, Gaglia, Jason L, Gottlieb, Peter A, Long, S Alice, Mari, Andrea, Mirmira, Raghavendra G, Raskin, Philip, Sanda, Srinath, Tsalikian, Eva, Wentworth, John M, Willi, Steven M, Krischer, Jeffrey P, Bluestone, Jeffrey A, Gleevec Trial Study Group
Publikováno v:
The lancet. Diabetes & endocrinology, vol 9, iss 8
BackgroundType 1 diabetes results from autoimmune-mediated destruction of β cells. The tyrosine kinase inhibitor imatinib might affect relevant immunological and metabolic pathways, and preclinical studies show that it reverses and prevents diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::0b6017dd19e135e30be952bcf76cb1c2
https://escholarship.org/uc/item/2hr6m8qw
https://escholarship.org/uc/item/2hr6m8qw
Autor:
Antoinette Moran, S. Alice Long, Susan Geyer, Megan V. Warnock, Linda A. DiMeglio, Henry Rodriguez, Jennifer B. Marks, Dorothy J. Becker, David A. Baidal, J Lori Blanchfield, Darrell M. Wilson, Peter A. Gottlieb, Stephen E. Gitelman, Desmond A. Schatz, Brian N. Bundy, Jessica L. Miller, Mark A. Atkinson, Michael J. Haller, Jay S. Skyler, Carla J. Greenbaum, Robin Goland, Jeffrey P. Krischer, Kevan C. Herold, William E. Russell
Publikováno v:
Diabetes
A three-arm, randomized, double-masked, placebo-controlled phase 2b trial performed by the Type 1 Diabetes TrialNet Study Group previously demonstrated that low-dose anti-thymocyte globulin (ATG) (2.5 mg/kg) preserved β-cell function and reduced HbA